Adam Jeremiah Kuzmiak, CRNA | |
3724 W Ashton Ct, Anthem, AZ 85086-2761 | |
(623) 249-4207 | |
Not Available |
Full Name | Adam Jeremiah Kuzmiak |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 13 Years |
Location | 3724 W Ashton Ct, Anthem, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992088298 | NPI | - | NPPES |
Z148617 | Other | AZ | MEDICARE PTAN |
664809 | Medicaid | AZ |
Facility Name | Location | Facility Type |
---|---|---|
Abrazo Scottsdale Campus | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Summit Anesthesia Services Pllc | 3971850892 | 46 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Entity Name | Dec Anesthesia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093006520 PECOS PAC ID: 9335319086 Enrollment ID: O20110907001087 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Entity Name | Greater Anesthesia Solutions |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124430244 PECOS PAC ID: 9234357906 Enrollment ID: O20140822000525 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Entity Name | Summit Anesthesia Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821589144 PECOS PAC ID: 3971850892 Enrollment ID: O20180724002694 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Entity Name | Summit Anesthesia Pain Services Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598222812 PECOS PAC ID: 0547500563 Enrollment ID: O20190328001717 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Entity Name | Desert Anesthesia Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750013223 PECOS PAC ID: 8729461207 Enrollment ID: O20220816001930 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Adam Jeremiah Kuzmiak, CRNA 3724 W Ashton Ct, Anthem, AZ 85086-2761 Ph: (623) 249-4207 | Adam Jeremiah Kuzmiak, CRNA 3724 W Ashton Ct, Anthem, AZ 85086-2761 Ph: (623) 249-4207 |
News Archive
Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Lexicomp has been selected by the University Health Network (UHN) as the drug information resource for its four hospitals located in Toronto, Canada.
Since the sequencing of the human genome in 2001, all our genes - around 20,000 in total - have been identified. But much is still unknown - for instance where and when each is active. Next to each gene sits a short DNA segment, and the activity of this regulatory segment determines whether the gene will be turned on, where and how strongly.
How can the U.S. health-care system and more specifically, primary care doctors - the physicians from whom older adults receive most of their care - prepare for the huge wave of dementia patients expected to engulf us in 2010, the year the baby boomers begin to reach 65?
› Verified 2 days ago